Table 3.
Outcome | Number of outcomes if 1000 patients were treated |
Number of outcomes caused or prevented by implant therapy (NX = NX,SYS - NX,IMP)* |
Weight assigned to the outcome (WX) |
NX * WX | |
---|---|---|---|---|---|
Treated with implant therapy (NX,IMP) |
Treated with systemic therapy (NX,SYS) |
||||
Visual acuity of the better-seeing eyes remained at worse than 20/40 or decreased to worse than 20/40 | 280 | 211 | −69 | 0.8 | −55 |
Incident glaucoma† | 226 | 60 | −166 | 0.7 | −116 |
Requiring cataract surgery | 612 | 252 | −359 | 0.6 | −216 |
Requiring glaucoma surgery | 331 | 67 | −263 | 0.6 | −158 |
Incident cataracts‡ | 173 | 86 | −87 | 0.3 | −26 |
Prescription-requiring hypertension | 41 | 76 | 34 | 0.3 | 10 |
Prescription-requiring hyperlipidemia | 25 | 67 | 42 | 0.3 | 13 |
Prescription-requiring infections | 369 | 479 | 110 | 0.2 | 22 |
| |||||
Benefit-harm metric (IX) | −526 |
Numbers of outcomes caused are negative and numbers of outcomes prevented are positive.
Assuming 97% of patients at risk at baseline.
Assuming 18% of patients at risk at baseline.